Our Team

Patrick Arensdorf


Founder & Chief Executive Officer

Pat brings more than 20 years of leadership experience as a healthcare entrepreneur to his role as co-founder and CEO of Exai. He previously served as an Entrepreneur-in-Residence at the University of California, San Francisco Innovation Ventures. Prior to Exai and UCSF, Pat was co-founder and CEO for Bluestar Genomics, CEO for Critical Diagnostics, and a member of the founding management teams at Tethys Bioscience (acquired by HDL) and Intersect ENT (acquired by Medtronic). Pat began his career as a financial advisor and strategy consultant in the private equity industry, entering the diagnostic field as the turnaround CEO for First Medical (acquired by Sigma-Aldrich). He has a master’s degree in management from the Stanford Graduate School of Business and a bachelor's degree in molecular biology from Princeton University.

Close the cookie popup
Cookie Settings
By clicking "Accept All", you are agreeing to store cookies on your device to enhance your experience and help Exai's marketing.
Accept All
cookie settings